Pateño, Cecile P.

HRN: 28-90-69  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2026
CEFTRIAXONE 1G (VIAL)
04/27/2026
05/03/2026
IV
2g
OD
Herniated Nucleus Pulposus L4L5
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: